News
Treating coronary artery disease patients with monotherapy using clopidogrel or ticagrelor was associated with lower rates of ...
Ticagrelor Market Analysis 2025 – Insights For Long-Term Investment & PlanningFuture growth predictions for the ticagrelor market remain optimistic. The market is projected to reach $2.57 billion in ...
An investigation has uncovered evidence of significant misreporting, raising new concerns about the approval and long-term use of ticagrelor over the past decade. In a follow-up investigation into the ...
Less than a year ago, Pete Hegseth and Jennifer Griffin were colleagues at Fox News Channel. But on Thursday, as defense secretary, Hegseth attacked Pentagon reporter Griffin at a news conference.
Iran has long been suspected of hiding work toward a nuclear weapon at its underground Fordo enrichment site.
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
In a follow up investigation into the multibillion dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval. For more than a decade, ...
The twice-daily pill is given to people with acute coronary syndrome -a sudden reduction of blood to the heart-reducing the risk of deadly clots and strokes.
Hosted on MSN28d
Top medics issue warning over heart drug - AstraZeneca accused of 'misreporting' dataAnti-clotting pill ticagrelor was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack. The twice-daily pill, sold as Brilinta, is given to ...
In a follow-up investigation into the multibillion-dollar drug ticagrelor, The BMJ has uncovered fresh concerns, this time in key platelet studies used in its FDA approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results